Lymphadenectomy in minimally invasive urologic oncology

Current Opinion in Urology

Volumn 18, Issue 2, 2008, Pages 163-166

  Vanni, Alex J ^a   Moinzadeh, Alireza ^a,b  

^a Institute of Urology Robotic and Laparoscopic Surgery   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Laparoscopy; Lymphadenectomy; Neoplasm; Robotics; Urologic oncology

Indexed keywords

BLADDER CANCER; CANCER SURVIVAL; CYSTECTOMY; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT OUTCOME;

HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; UROGENITAL NEOPLASMS;

EID: 39849095219     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f4f00b     Document Type: Review

References (37)

1. Bader P, Burkhard FC, Markwalder R, et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003; 169:849-854.
2. Daneshmand S, Quek ML, Stein JP, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. J Urol 2004; 172:2252-2255.
3. Allaf ME, Palapattu GS, Trock BJ, et al. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J Urol 2004; 172:1840-1844.
4. Joslyn S, Konety B. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006; 68:121-125.
5. Masterson TA, Bianco FR Jr, Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006; 175:1320-1324.
6. Gil-Vernet JM. Prostate cancer: Anatomical and surgical considerations. Brit J Urol 1996; 78:161-168.
7. Heidenreich A, Ohlmann CH, Polyakou S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 2007; 52:29-37.
8. Dhar NB, Burkhard FC, Studer UE. Role of lymphadenectomy in clinically organ-confined prostate cancer. World J Urol 2007; 25:39-44.
9. Sivalingam S, Oxley J, Probert JL, et al. Role of pelvic lymphadenectomy in prostate cancer management. Urology 2007; 69:203-209.
10. Heidenreich A, von Knobloch R, Varga Z. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy in prostate cancer: High incidence of lymph node metastases. J Urol 2001; 167:1681-1684.
11. Heidenreich A, von Knobloch R, Varga Z, et al. Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy-data on >300 cases [abstract]. Proc Annu Meet Am Assoc Cancer Res 2005; 22:409s.
12. Wyler SF, Sulser T, Seifert H, et al. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology 2006; 68:883-887.
13. Touijer K, Rabbani F, Otero J, et al. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. J Urol 2007; 178:120-124. This is the first article to determine the yield of a standard versus limited pelvic lymphadenectomy performed laparoscopically.
14. Poulsen AL, Horn R, Steven K. Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160:2015-2019.
15. Leissner J, Hohenfellner R, Thuroff JW, et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: Significance for staging and prognosis. BJU Int 2000; 85:817-823.
16. Brossner C, Pycha A, Totha A, et al. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004; 93:64-66.
17. Herr H, Bochner BH, Dlabagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;1295-1298.
18. Stein JP, Cai J, Groshen S, et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: Concept of lymph node density. J Urol 2003; 170:35-41.
19. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol 2004; 22:2781-2789.
20. Konety BR, Joslyn SA, O'Donnel MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the surveillance, epidemiology and end results program database. J Urol 2003; 169:945-950.
21. Porpiglia F, Renard J, Billia M, et al. Open versus laparoscopy-assisted radical cystectomy: Results of a prospective study. J Endourol 2007; 21:325-327.
22. Gerullis H, Kuemmel C, Popken G. Laparoscopic cystectomy with extracorporeal-assisted urinary diversion: Experience with 34 patients. Eur Urol 2007; 51:193-198.
23. Haber GP, Gill IS. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years. BJU Int 2007; 100:137-142. This paper provides the longest oncologic follow-up on a group of patients who underwent laparoscopic cystectomy with extended lymphadenectomy.
24. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001; 19:666-675.
25. Menon M, Hemal AK, Tewari A, et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int 2003; 92:232-236.
26. Menon M, Hemal AK, Tewari A, et al. Robot-assisted radical cystectomy and urinary diversion in female patients: Technique with preservation of the uterus and vagina. J Am Coll Surg 2004; 198:386-393.
27. Guru KA, Kim HL, Piancente PM, et al. Robot-assisted radical cystectomy and pelvic lymph node dissection: Initial experience at Roswell Park Cancer Institute. J Urol 2007; 69:469-474. The article provides a good detailed description of robotic assistance with short-term outcomes.
28. Lee C, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000; 163:730.
29. Marshall F, Stewart AK, Menck HR. The National Cancer Database: Report on kidney cancers. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1997; 80:2167.
30. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101:297-301.
31. Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 1999; 36:570-575.
32. Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: Role of lymph node dissection. J Urol 2003; 169:2076.
33. Canfield SE, Ashish MK, Sanchez-Ortiz RF, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (Clinical stage TxN1-2M0): The impact of aggressive surgical resection on patient outcome. J Urol 2006; 175:864-869.
34. Vasselli JR, Yang JC, Linehan WM, et al. Lack of retroperitoneal lymphadenectomy predicts survival of patients with metastatic renal cell carcinoma. J Urol 2001; 166:68.
35. Pantuck AJ, Zisman A, Dorey FJ, et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 2003; 95:2995.
36. Simmons MN, Kaouk J, Gill IS, et al. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. J Urol 2007; 70:43-46. This manuscript addresses laparoscopic radical nephrectomy and retroperitoneal lymphadenectomy. The authors found that the procedure is safe and feasible in select patients.
37. Permongkosol S, Lima GC, Warlick CA, et al. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: Evaluation of complications. Urology 2007; 69:361-365.